Risperdal Side Effects Include Gynecomastia in Young Boys
The Strom Law Firm, L.L.C. is currently accepting cases of young boys using the antipsychtoic drug Risperdal and developing male breasts, (a.k.a. Gynecomastia). Many doctors have prescribed Risperdal for unapproved uses, which led to serious consequences. If you or a loved one have experienced side effects or complications after using Risperdal you may be eligible to file a claim against Johnson & Johnson.
Currently, at least 230 Risperdal lawsuits are pending in a mass tort proceeding, which is underway in Philadelphia Court of Common Pleas. However, there are more personal injury lawsuits against Johnson & Johnson pending in state courts all over the country. All of the lawsuits allege that Risperdal can increase hormone levels in boys and young men, which can lead to several long-term problems, as well as male breast development.
In one particular lawsuit, the plaintiff, who is now 18 years old, began taking Risperdal at only 7 years old – between 2002 and 2008. At the time he began using the anti-psychotic, it was not approved for use in children or adolescents – the FDA would not approve Risperdal for pediatric use until 2006. The plaintiff claims that J&J subsidiary Janssen promoted Risperdal’s use in children with criminal and reckless disregard for their welfare. The plaintiff is also suing non-Johnson & Johnson publishers of scientific materials, which claim that pediatric use of Risperdal is safe. He accuses them of conveying false information and misleading materials about the safety of Risperdal.
The plaintiff, whose case is in the Circuit Court of Cook County, Illinois, says that as a result of using Risperdal as a child, he suffered rapid weight gain, serious and permanent injury to his endocrine and sexual systems, gynecomastia, as well as other permanent physical and emotional damages. His lawsuit alleges that Janssen and J&J committed negligence, fraud, failure to warn, strict product liability, breach of express and implied warranties, conspiracy against defendants, and violation of the Illinois Unfair Trade Practices Act.
What Is Risperdal?
Risperdal is an atypical antipsychotic drug which is mainly used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed and manic states associated with bipolar disorder, and irritability in people with autism.
Risperidone belongs to the class of atypical antipsychotics. It is a dopamine antagonist possessing antiserotonergic, antiadrenergic and antihistaminergic properties.
The use of Risperdal (risperidone) in young men has been linked to a condition called gynecomastia, or the enlargement of male breast tissue. Gynecomastia may occur unilaterally or bilaterally, presenting with swollen breast tissue or breast tenderness, which may lead affected individuals to be concerned about the possibility of having breast cancer. An increase in the diameter of the areola or asymmetry of chest tissue are other possible signs of gynecomastia.
In September 2012, Johnson & Johnson settled the first Risperdal gynecomastia lawsuit.
Lawsuits filed against J&J allege that the drug causes an increase in the levels of the lactation hormone prolactin, which stimulates breast growth development.
If you or someone you know has been affected by the side effects of Risperdal, such as Gynecomastia, and would like to know how the Strom Law Firm, L.L.C. can help, contact us today at 803-252-4800. You can also click to chat or fill out the form in the sidebar.